Misplaced Pages

Almagate: Difference between revisions

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Browse history interactively
Page 1
Page 2
← Previous editContent deleted Content addedVisualWikitext
Revision as of 20:27, 6 August 2011 editCheMoBot (talk | contribs)Bots141,565 edits Updating {{drugbox}} (no changed fields - added verified revid - updated 'DrugBank_Ref', 'ChEMBL_Ref', 'ChEBI_Ref', 'ChEBI_Ref') per Chem/Drugbox validation (report [[Misplaced Pages talk:WikiProject_P← Previous edit Latest revision as of 07:22, 31 December 2023 edit undoWhywhenwhohow (talk | contribs)Autopatrolled, Extended confirmed users, Pending changes reviewers48,667 edits top: infobox 
(7 intermediate revisions by 7 users not shown)
Line 1: Line 1:
{{Short description|Chemical compound}}
{{drugbox
{{Drugbox
| verifiedrevid = 443400546
| IUPAC_name =
| image = <!--Almagate.svg-->

<!--Clinical data-->
| tradename =
| Drugs.com = {{drugs.com|international|almagate}}
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B / C / D / X -->
| pregnancy_category =
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status =
| routes_of_administration = Oral

<!--Pharmacokinetic data-->
| bioavailability =
| protein_bound =
| metabolism =
| elimination_half-life =
| excretion =

<!--Identifiers-->
| CAS_number = 66827-12-1
| ATC_prefix = A02
| ATC_suffix = AD03
| PubChem = 71749
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 64792
| UNII_Ref = {{fdacite|correct|FDA}} | UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 568Z59H7ZJ | UNII = 568Z59H7ZJ
| KEGG_Ref = {{keggcite|correct|kegg}}
| verifiedrevid = 437148482
| KEGG = D02821
| IUPAC_name =

| image = <!--Almagate.svg-->
<!--Chemical data-->
| InChI = 1/CH2O3.Al.3Mg.9H2O/c2-1(3)4;;;;;;;;;;;;;/h(H2,2,3,4);;;;;9*1H2/q;+3;3*+2;;;;;;;;;/p-9
| chemical_formula = Al<sub>2</sub>Mg<sub>6</sub>(OH)<sub>14</sub>(CO<sub>3</sub>)<sub>2</sub> · 4 H<sub>2</sub>O
| molecular_weight = 314.99
| molecular_weight_comment = g/mol
| smiles = .......C()=O.....O.O | smiles = .......C()=O.....O.O
| InChIKey = MTEOMEWVDVPTNN-MBBIINEJAH
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} | StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/CH2O3.Al.3Mg.9H2O/c2-1(3)4;;;;;;;;;;;;;/h(H2,2,3,4);;;;;9*1H2/q;+3;3*+2;;;;;;;;;/p-9 | StdInChI = 1S/CH2O3.Al.3Mg.9H2O/c2-1(3)4;;;;;;;;;;;;;/h(H2,2,3,4);;;;;9*1H2/q;+3;3*+2;;;;;;;;;/p-9
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} | StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = MTEOMEWVDVPTNN-UHFFFAOYSA-E | StdInChIKey = MTEOMEWVDVPTNN-UHFFFAOYSA-E
| CAS_number = 66827-12-1
| ATC_prefix = A02
| ATC_suffix = AD03
| PubChem = 71749
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 64792
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D02821
| chemical_formula = Al<sub>2</sub>Mg<sub>6</sub>(OH)<sub>14</sub>(CO<sub>3</sub>)<sub>2</sub> · 4 H<sub>2</sub>O
| molecular_weight = 314.99 g/mol
| bioavailability =
| protein_bound =
| metabolism =
| elimination_half-life =
| excretion =
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B / C / D / X -->
| pregnancy_category=
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status =
| routes_of_administration = Oral
}} }}
'''Almagate''' (trade name '''Almax''') is an ]- and ]-containing ]. It was first described in 1984.<ref>{{cite pmid|6548918}}</ref><ref>{{cite pmid|6439224}}</ref> '''Almagate''' (trade name '''Almax''') is an ]- and ]-containing ]. It was first described in 1984.<ref>{{cite journal | vauthors = Moragues J, Beneyto JE, Fábregas JL, Spickett RG | title = Characterization of a new crystalline synthetic gastric antacid, almagate | journal = Arzneimittel-Forschung | volume = 34 | issue = 10A | pages = 1346–9 | year = 1984 | pmid = 6548918 | url = http://toxnet.nlm.nih.gov/cgi-bin/sis/search/r?dbs+hsdb:@term+@rn+21645-51-2 | format = Free full text }}</ref><ref>{{cite journal | vauthors = Beneyto JE, Fábregas JL, Moragues J, Spickett RG | title = Evaluation of a new antacid, almagate | journal = Arzneimittel-Forschung | volume = 34 | issue = 10A | pages = 1350–4 | year = 1984 | pmid = 6439224 | url = http://toxnet.nlm.nih.gov/cgi-bin/sis/search/r?dbs+hsdb:@term+@rn+21645-51-2 | format = Free full text }}</ref>


== Adverse effects == == Adverse effects ==
Almagate is well tolerated. In a ], the most common ]s were diarrhea and nausea.<ref>{{cite pmid|6548926}}</ref> Almagate is well tolerated. In a ], the most common ]s were diarrhea and nausea.<ref>{{cite journal | vauthors = Suau A, Dominguez Martin A, Ferrando Cucarella J, Juncosa Iglesias L, Muñoz Benitez J, Nieto Calvet M, Pérez Gieb J, Pérez Mota A, Pineda Garcia A, Rodriguez Sanchez E | display-authors = 6 | title = Treatment of gastric pyrosis with almagate in patients with and without endoscopically demonstrable duodenal ulcer. A multicentre clinical trial | journal = Arzneimittel-Forschung | volume = 34 | issue = 10A | pages = 1380–3 | year = 1984 | pmid = 6548926 | url = http://toxnet.nlm.nih.gov/cgi-bin/sis/search/r?dbs+hsdb:@term+@rn+21645-51-2 | format = Free full text }}</ref>


== References == == References ==
Line 52: Line 62:
] ]
] ]



{{gastrointestinal-drug-stub}} {{gastrointestinal-drug-stub}}

]